SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MRNS, RHE, SSY, CTV on Behalf of Shareholders
1. Halper Sadeh investigating MRNS for potential legal violations regarding share sale. 2. MRNS's sale to Immedica Pharma AB is priced at $0.55 per share. 3. Investors may seek increased consideration related to the sale. 4. Legal rights and options for MRNS shareholders are being explored. 5. The firm has a history of aiding defrauded investors successfully.